The high prevalence of goiter among adults in its member countries of Central America and Panama was observed as soon as INCAP began field studies. This led to systematic studies of goiter in schoolchildren in all of the countries as described, beginning with Guatemala where the rate was 38% nationally.
Introduction
Soon after the Institute of Nutrition of Central America and Panama (INCAP) began its first nutrition field studies in Guatemala in 1949, it was apparent that swollen necks indicative of enlarged thyroid glands were common among both adults and children in the highland villages. For this reason, Dr. O. P. Kimball was invited to INCAP as a consultant in May 1950, only nine months after its inauguration. Dr. Kimball and David Marine had identified the high prevalence of endemic goiter in Michigan and Ohio in the 1930s and had demonstrated the effectiveness of iodized salt for its prevention.
In the Mayan Indian village Santa María de Jesús, on the side of the Agua Volcano, Kimball taught us the techniques of palpation of the neck to determine endemic goiter, and we began goiter surveys in all of the member countries. In this village, we found a high prevalence of goiter in both children and adults. Some goiters in children were nodular; in adults, both nodular and large, fibrotic goiters were common.
The nodular goiters in children were interpreted by Dr. Kimball as an indication of severe iodine deficiency during pregnancy, which he believed to be associated with increased deaf-mutism and, in adults, possibly an increased risk of thyroid carcinoma. It was also known that severe iodine deficiency in pregnancy could result in cretinism (dwarfism with mental retardation). However, many years passed before it was recognized that even mild-to-moderate iodine deficiency in pregnant women could depress the IQ of the offspring [1] .
On the basis of successful experience in the United States, Dr. Kimball urged that we complete a representative goiter survey of Guatemala and then strive for the iodation of all salt for human consumption. The Guatemala national survey was completed in schoolchildren in 22 departments [2] [3] [4] .
Among 26,024 children under 12 years of age, the goiter prevalence was 34.2%. Among 9,278 adolescents aged 13 to 19 years, the prevalence was 46.0%, and among 4,475 adults it was 55.5% [2] . There was no Please direct queries to the author: Nevin S. Scrimshaw, Box 330, Campton, NH 03223, USA; e-mail:nscrimshaw@ inffoundation.org. significant difference in rates between the sexes. Nodular goiters were found in 2.2% of the children, 3.9% of the adolescents, and 24.1% of the adults. The average prevalence for all types of goiters, weighted for population differences among departments, was 38.5%. Four highland departments (Baja Vera Paz, Chimaltenango, Sacatepequez, and San Marcos) had rates ranging from 54% to 59%, and only the northern department of Coban had a goiter prevalence of less than 20%. Villages at about 500 m altitude had a goiter prevalence of more than 30%, and the rate increased with altitude to 50% for villages near 3,000 m. Among the inhabitants of the nine villages below 100 m, less than 10% had goiter. All of these findings appear in Muñoz et al. [2] .
Serum protein-bound iodine (PBI) was measured in the serum of 219 pregnant women in Guatemala as part of a study of serum lipid levels. PBI levels were significantly higher in pregnant women (8.9 ± 1.4 μg/100 mL) than in nonpregnant women (6.3 ± 0.9 μg/100 mL) and did not differ between higher and lower socioeconomic groups [5, 6] .
The effectiveness of adding potassium iodide to salt was well established in the United States and Europe, but the compound and the method used were impractical for Central America, where much of the salt was sold crude and moist from open piles in the markets. Under these circumstances, highly soluble potassium iodide would quickly drain to the bottom. Using potassium iodide would require drying the salt, refining it, adding a stabilizer, and selling it only in moisture-proof packages. This would be prohibitive in cost and pose problems of acceptability. Faced with this dilemma, I made finding a solution a high priority for INCAP. The CRC Handbook of Chemistry and Physics listed potassium iodate as insoluble, but there was no indication of its bioavailability [7] .
To explore the possible use of potassium iodate, we implemented a study of schoolchildren in the rural villages of Opico and Tonicatepeque, in El Salvador, and Ciudad Vieja and Santa María de Jesús, in Guatemala [8, 9] . The children were given one tablet per week, equivalent to the iodation of salt at a level of 1 part of iodine in 10,000 parts of salt, either as potassium iodide (4.5 g) or potassium iodate (8.5 g), or as an identicalappearing placebo [9] . The results for El Salvador are shown in figure 1. After 15 weeks of supplementation with either potassium iodide or potassium iodate, goiter prevalence fell sharply but returned to previous levels during the 12 weeks of school vacation. The results for Guatemala were similar. Goiter levels in the placebo groups did not change. This study in the two countries conclusively demonstrated the efficacy of potassium iodate. Our inquiries stimulated the World Health Organization (WHO) to sponsor laboratory studies in England [10, 11] and India [12] that showed that the iodine was released from potassium iodate by hydrolysis at the normal pH of the stomach and gastrointestinal tract. The protein-bound iodine levels of the Guatemalan children at the end of the study did not differ significantly among any of the groups [9] .
It still needed to be demonstrated that potassium iodate added to crude moist salt would remain evenly distributed under the hot and humid conditions of tropical lowlands. Guillermo Arroyave took the leadership for this testing. A 50-kg sample of salt with potassium iodate mixed in resulted in a level of one part of iodine in 10,000 parts of salt. The sample was secure, stored in a hemp fiber sack in an open room with an average humidity of approximately 70% for four dryseason months and about 84% for four rainy-season months at temperatures ranging from 20° to 40°C (70° to 100°F) [13] . The results showed that after 6 months under these conditions, the loss of iodine was only 5.8% in the top third of a 50-kg sack, 4.6% from the middle third, and zero from the bottom third.
With [16] . The English version of the final report of these surveys, published in the American Journal of Public Health [8] , showed an average goiter prevalence of 13% in the capitals of the departments and 29% for the populations outside the capital cities. One department, Ahuachapan, had a prevalence rate of 54%, and only the Department of Cabenez (with 9%) had a rate below 23%. In El Salvador, the rates were significantly higher among girls 10 years of age and older than among boys of the same age [16] .
Goiter surveys were soon extended to the other member countries of INCAP. In Nicaragua, the head of the Nutrition Unit of the Ministry of Health initially reported a goiter prevalence of 26.5% in 7,357 schoolchildren [17, 18] , later expanded to 15,500 individuals, including 11,360 schoolchildren between 6 and 12 years of age (5.5% of the children in this age group in the country). In the larger study, the prevalence rates were 25.3% for 9,093 children 6 to 12 years old, 32.2% for 4,090 adolescents 13 to 18 years of age, and 28.4% for 2,317 persons 19 years of age or older [17] . For females over the age of 13, the rate was nearly 39%. These findings were subsequently published in more detail, with analysis of the geographic distribution in the country [19] , reporting an 11% prevalence of nodular goiter.
Eight years later, 13,814 persons were examined in 16 Nicaraguan communities prior to iodation of salt. * Ironically, the paper presenting these data had the subtitle "Final Report" in Spanish, but it was not to be the end of the story. During the political turbulence of the 1980s, the Ministry of Health stopped monitoring the iodation of salt, and endemic goiter returned. In some populations, it was as severe as in the 1950s. When a new government enforced the iodation law once again, endemic goiter soon ceased to be a problem.
Of these individuals, 33% had goiter, of which 5% were nodular [20] . In an effort to identify more quantitative evidence of iodine deficiency, serum levels of T3, total T4, and thyrotropin and T3 uptake by T30 resin were examined in 919 individuals randomly selected in 16 Nicaraguan communities [21] . The data indicated that values for euthyroid individuals were higher than for those with chronic iodine deficiency. A tendency toward biochemical hyperthyroidism was observed in individuals with large nodular or diffuse goiters and in women 16 to 45 years of age who used oral contraceptives [19, 22] .
In Costa Rica, goiter prevalence was 13.2% in girls 7 to 12 years of age and 10.4% in boys of the same age. Among adolescent girls 13 to 18 years of age, the rate was 23.8%, and for boys of this age it was 19.4% [23] . In Honduras, a survey of 12,644 individuals, all but 352 of them schoolchildren, reported a goiter prevalence of 23.2% in those aged 6 to 12 and 29.7% in those aged 13 to 18 [24, 25] . In Panama, the prevalence rates of goiter were typically high (21% to 60% in schoolchildren and 17% to 75% in adults) [26] [27] [28] [29] , highlighted by an INCAP study in Panama's Las Tablas Peninsula region by Reverte and Pérez [30] . This study reported a high regional prevalence of cretinism and polydactylism along with goiter. Most of the area is near sea level and not far from the sea, so this was an unexpected result. It can be explained, however, by the heavy rains of the Pacific coast (over 400 cm per year), which deplete the soils of iodine; the river waters coming from the highlands were similarly iodine poor. Moreover, iodine-rich seafood was not a common part of the local diets. The prevalence rates for the countries of Central America and Panama based on these studies in the 1950s are summarized in table 2 [31] [32] [33] [34] [35] [36] [37] .
The iodine content of the salt samples from each of the member countries of INCAP was analyzed [38] . Values ranged from 0.02 to 0.11 mg/10 g of salt. As anticipated, these levels were not sufficient to meet iodine needs or prevent the development of endemic goiter, and they decreased with increasing duration of storage.
Between The studies included not only a physical examination but also the determination of urinary iodine [39] . A summary publication [37] describes the findings for all six countries. The urinary iodine results are very low, except in Guatemala ( fig. 2) . These findings illustrate the dramatic effect of salt iodation in Guatemala.
The clinical appraisal of the presence of goiter requires training and the ability to make a consistent subjective appraisal. We were fortunate in being trained by a world authority, Dr. O. P. Kimball, who required standardization of criteria through repeated, double-blind comparisons. After Pérez, Muñóz, and I completed the training and surveys in Guatemala, we taught the procedures to directors of field teams of the other countries. Adela Cabezas, head of the nutrition field team of the Ministry of Health of El Salvador, did the clinical examinations for the survey in El Salvador. For the iodate comparisons in El Salvador, we each independently examined every child for the iodide/ iodate trials in El Salvador described above [8, 9] . The classification system used by Dr. Kimball was to assign category 3 to individuals with large goiters visible at a distance, category 2 to those readily visible with the head in normal position, category 1 to those that were judged to be more than three to four times enlarged, and category 0 or normal for those less enlarged. We were told to visualize the lateral lobes of the thyroid as shaped like a lima bean, about the size of the thumbnail of the person being examined, in order to estimate total volume and allow for differences in body size.
The pretreatment examination was not difficult, because most of the goiters were visible with the subject's head thrown back and were palpable. However, after treatment, the remaining goiters were mostly borderline in size, and each decision was difficult. It not only required much more time, but also we were usually not sure that we had classified these borderline glands correctly. We found that we could arrive at a decision more quickly if we added the categories "1−" and "0+. " They were still tabulated as "0" or "1. " In the examinations that followed treatment, each of us arrived at the same average result within a few tenths of a percent. However, we were surprised to find that we differed on about 20% of individuals. These were almost all children who had been rated as 0+ or 1− by one of us and given the reverse rating by the other. This was confirmation of the reliability for public health purposes of clinical examination by trained observers. Later, Pérez organized the initial surveys in the other INCAP member countries, and I trained physicians in a number of other Latin American countries. Much later, Muñóz, as a WHO nutrition advisor for Africa, carried out a number of goiter surveys and trained a generation of African physicians in the technique of goiter examination.
When I attended a WHO meeting on endemic goiter in Geneva in 1960, it was apparent that a standard description of the examination technique was needed, and INCAP was asked to provide it. Two articles [42, 43] described the technique of physical examination and proposed the classification of endemic goiter (table 3) . Sample selection, data tabulation, and interpretation were also discussed in this article. It provided the global standard for the next 20 years. It was only in 1979 that a new WHO working group introduced more categories in order to satisfy clinicians, although they contributed little or nothing to the public health significance of the findings [44] .
Kimball had informed us that in the original salt iodation trials in Michigan and Ohio, clinics were established to deal with cases of thyrotoxicosis, but not a single case was observed. Similarly, none were reported to us after iodation of salt in Guatemala. However, in an abstract reporting on a preiodation survey in Nicaragua, Viteri et al. [45] noted that hospitals in Panama, in 1972, and Costa Rica, in 1973, saw a fourfold increase in thyrotoxicosis after salt iodation, mainly in adult women. Further details were not given, but these may have been the first observations of transient thyrotoxicosis following prophylactic iodation of salt.
In a preiodation survey of 13,814 adults in 16 cities and towns in Nicaragua, questions were asked about changes in body weight and symptoms that might be related to hyper-or hypothyroidism [20] . Symptoms of hypothyroidism were seen in 2.5% of those surveyed. This made us even more skeptical of the significance of the sporadic reports of thyrotoxicosis as an aftereffect of salt iodation at an appropriate level. However, higher T3 and free thyroxine index levels were related to the presence of four or more nonspecific signs and symptoms of hyperthyroidism [22] . This was interpreted to suggest that such individuals are at a greater risk of developing clinical hyperthyroidism when the iodine intake increases. Treatment of thyrotoxicosis was discussed in a 1953 paper [46] .
After the publication of our report on endemic goiter in Guatemala, we received a letter from a professor of chemistry in Colombia claiming that goiter was an infectious disease brought to the New World from Egypt by the Spaniards and that the disappearance of goiter after iodation was a therapeutic effect. About this time, an archaeologist brought to our attention figurines in the National Museum of Anthropology and Archaeology in Guatemala with what appeared to be enlarged thyroid glands, dated approximately 500 and 2,000 BC [47] . Our publication noted a clear description of goiter in Sacapulas, Guatemala, by Thomas Gage in 1648, a town with a 37% goiter prevalence in 1955.
Although nearly all of INCAP's goiter research involved human studies, there was a study of the effect of calcium and iodine on the experimental production of goiter in the rat, showing that calcium had no effect on the weight of the thyroid gland or on its iodine content [48] .
As the extent of INCAP experience with endemic goiter became widely recognized, many requests were received for review articles. The earliest of these appeared in the Boletín de la Oficina Sanitaria Panamericana [49] . Others were published in Nutrition Reviews [50] , Public Health Reports [51] , as a chapter in the booklet Control of Nutrition in Man [52] , and as a chapter in the book The Thyroid [53] . A 1966 review examined the efficacy of salt enrichment with iodine for the prevention of endemic goiter [14] . It documented the positive results of such enrichment in many different countries, despite the wide range Persons with visible goiters Persons whose goiters are easily visible with the head in normal position. Palpation is helpful in determining the mass of the gland but not needed for diagnosis Group 3 Persons with very large goiters Persons whose goiters can easily be recognized at a considerable distance, grossly disfiguring and of a size to cause difficulties with respiration and fit of clothes Source: Perez et al. [42] . a. The technique involves the examiner sitting or standing facing the patient, gently using thumbs on either side of the thyroid area to palpate the gland and determine its size.
of fortification levels used. A 1968 review examined the progress and delays in combating goiter in Latin America [54] . The most recent review was published in June 1994 as a Pan American Health Organization (PAHO) document [55] .
Concluding comment
As this article points out, INCAP made three major contributions in the 1950s to the conquest of endemic goiter that, as a result of the current efforts of the International Commission for the Control of Iodine Deficiency Disorders (ICCIDD), UNICEF, Asian Development Bank (ADB), and WHO, is now becoming a reality in many countries.
The first was the demonstration that potassium iodate could be used effectively for iodation of crude, moist salt.
The second was the confirmation of a prompt fall in goiter prevalence with iodation on a national scale. This had been previously demonstrated with potassium iodide fortification in Europe, and on a voluntary basis in the United States and for a short time in the State of Caldas in Colombia. However, Guatemala was the first successful example of the use of potassium iodate fortification on a national scale.
The third was the transmission of the experience of Marine and Kimball to subsequent generations through the training of Latin American physicians in Guatemala who, in turn, trained others in Latin America and Africa. An INCAP-authored article describing the method was the template for the WHO international standard methodology [43] .
Finally, endemic goiter occurs because the environment is deficient in iodine, leading to low levels of iodine in local plant and animal foods. As Guatemala demonstrated, goiter cannot be eradicated without a measure that permanently provides the additional iodine needed by a population. As long as iodine remains deficient in the environment and diets are based primarily on local foods, fortification of salt or other staple food with an available form of iodine will be required. Thus, when salt iodation is introduced, it is essential to institutionalize a surveillance mechanism that will be maintained indefinitely.
